These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 27896684)

  • 21. Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs.
    Davis M; Walker G
    J Control Release; 2018 Jan; 269():110-127. PubMed ID: 29117503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the Dependence of the Flory-Huggins Interaction Parameter on Temperature and Composition in a Drug-Polymer System.
    Potter CB; Davis MT; Albadarin AB; Walker GM
    Mol Pharm; 2018 Nov; 15(11):5327-5335. PubMed ID: 30259745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rational approach towards development of amorphous solid dispersions: Experimental and computational techniques.
    Chakravarty P; Lubach JW; Hau J; Nagapudi K
    Int J Pharm; 2017 Mar; 519(1-2):44-57. PubMed ID: 28063904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ; Shamblin SL; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties.
    Mann AKP; Schenck L; Koynov A; Rumondor ACF; Jin X; Marota M; Dalton C
    J Pharm Sci; 2018 Jan; 107(1):183-191. PubMed ID: 28711592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.
    Baghel S; Cathcart H; O'Reilly NJ
    Eur J Pharm Biopharm; 2016 Oct; 107():16-31. PubMed ID: 27378287
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
    Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidating spray-dried dispersion dissolution mechanisms with focused beam reflectance measurement: contribution of polymer chemistry and particle properties to performance.
    Rawlinson-Malone CF; Ferreira AP; Nicholls D; Nicholson S
    Pharm Dev Technol; 2019 Nov; 24(9):1055-1062. PubMed ID: 30640552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase behavior of pharmaceutically relevant polymer/solvent mixtures.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Int J Pharm; 2020 Mar; 577():119065. PubMed ID: 31988034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How changes in molecular weight and PDI of a polymer in amorphous solid dispersions impact dissolution performance.
    Auch C; Harms M; Mäder K
    Int J Pharm; 2019 Feb; 556():372-382. PubMed ID: 30553957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu.
    Curatolo W; Nightingale JA; Herbig SM
    Pharm Res; 2009 Jun; 26(6):1419-31. PubMed ID: 19277850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amorphous solid dispersions: a robust platform to address bioavailability challenges.
    Newman A; Nagapudi K; Wenslow R
    Ther Deliv; 2015 Feb; 6(2):247-61. PubMed ID: 25690090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solvent-Assisted Secondary Drying of Spray-Dried Polymers.
    Shepard KB; Dower AM; Ekdahl AM; Morgen MM; Baumann JM; Vodak DT
    Pharm Res; 2020 Jul; 37(8):156. PubMed ID: 32737611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
    Hugo M; Kunath K; Dressman J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of spray-drying parameters on phase behavior, drug distribution, and in vitro release of injectable microspheres for sustained release.
    Meeus J; Lenaerts M; Scurr DJ; Amssoms K; Davies MC; Roberts CJ; Van Den Mooter G
    J Pharm Sci; 2015 Apr; 104(4):1451-60. PubMed ID: 25648704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Delayed Release Oral Formulation Comprising Esomeprazole Spray Dried Dispersion Utilizing Design of Experiment As An Optimization Strategy.
    Patel K; Patel J; Shah S
    AAPS PharmSciTech; 2023 Sep; 24(7):186. PubMed ID: 37700215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles.
    Šoltys M; Kovačík P; Dammer O; Beránek J; Štěpánek F
    Int J Pharm; 2019 Jan; 555():19-27. PubMed ID: 30395956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L; Mann AKP; Liu Z; Milewski M; Zhang S; Ren J; Dewitt K; Hermans A; Cote A
    Int J Pharm; 2019 Mar; 559():147-155. PubMed ID: 30654058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.